Clinical Trials
3
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable
- Conditions
- Cardiopulmonary FailureMyocardial Infarction (MI)Heart DecompensationHeart FailureHFrEF - Heart Failure with Reduced Ejection FractionHFpEF - Heart Failure with Preserved Ejection FractionSyncopationSyncopeIschemic Cardiovascular DiseaseSTEMI
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-01-08
- Lead Sponsor
- Peerbridge Health, Inc
- Target Recruit Count
- 15000
- Registration Number
- NCT06763549
- Locations
- 🇺🇸
Peerbridge Health, Melbourne, Florida 32935, Melbourne, Florida, United States
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Recruiting
- Conditions
- Ventricular Ejection FractionLVFLV DysfunctionAtrial EnlargementConduction DefectHeart FailureValvular Heart DiseaseIschemic Heart DiseaseCardiotoxicityMyocardial Infarction
- First Posted Date
- 2024-11-21
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Peerbridge Health, Inc
- Target Recruit Count
- 1500
- Registration Number
- NCT06699056
- Locations
- 🇺🇸
Orange County Heart Institute, Orange, California, United States
🇺🇸Peerbridge Health, Melbourne, Florida, United States
🇺🇸Henry Ford Hospital, Detroit, Michigan, United States
A Study to Determine the Feasibility of Wireless Electrocardiography
Completed
- Conditions
- Atrial FibrillationConduction DefectsNormal Sinus RhythmPremature Atrial and Ventricular Beats
- First Posted Date
- 2014-06-12
- Last Posted Date
- 2017-09-25
- Lead Sponsor
- Peerbridge Health, Inc
- Target Recruit Count
- 14
- Registration Number
- NCT02162394
- Locations
- 🇺🇸
Lenox Hill Hospital, New York, New York, United States
News
No news found